Distributors of Vaccines including Influenza

The contract pertains to New Mexico’s intent to participate in the MMCAP Infuse cooperative purchasing program for distributing vaccines, including influenza vaccines. The primary goal is to leverage collective buying power to secure better pricing and value for vaccines and related pharmaceutical services across state and local agencies. The solicitation, identified by number 60-00000-25-00013, was posted on September 11, 2025, with a response deadline of September 22, 2025. The contract value is estimated between five and twenty million dollars, with the NAICS code 424210 indicating wholesale drug and pharmaceutical distribution. The process involves a notice of intent to participate and a formal objection procedure, where interested parties can raise concerns via email before the deadline. The available documentation is limited to a notice of participation and does not include detailed contract clauses, terms, or conditions. No specific FAR clauses, standard contract forms, or detailed evaluation criteria are referenced. The scope covers distribution of vaccines, vaccination needles, devices, and related services, but lacks explicit technical specifications, packaging, labeling, or inspection requirements. Administrative contacts include a procurement specialist and MMCAP coordinators, with instructions for objections and general procurement procedures. The absence of detailed terms suggests that the actual contractual obligations, clauses, and performance standards are governed by the overarching MMCAP Infuse master contract, which is not included in the current documentation.